IDIVAL’s Clinical and Molecular Microbiology group has published a study that analyzes the survival of bacteria of the genus Acinetobacter on some of the most used surfaces in hospitals. The persistence of pathogenic bacteria in hospitals and health centers plays an important role in the onset of outbreaks and hospital-acquired infection. These bacteria survive in […]
Within Valdecilla Biosanitary Strategic Enhancement Program, IDIVAL has called the NEXT-VAL (NEXT generation VALdecilla) grant for the development of research projects led by novel researchers, in order to facilitate the development of new generations of researchers. According to the terms of the call, the main researchers of the projects are under the age of 40, […]
What is the Dementia Consortium? The Dementia Consortium supports collaborative target validation and drug discovery projects from academia and SMEs. They offer a unique collaborative model bringing together the charity and industry sectors to help accelerate development of therapies for novel dementia targets. What do they offer? The Dementia Consortium provides drug discovery resources, project […]
The next day 6 of September will take place within the Summer Courses of the International Menéndez Pelayo University the Conference entitled “Synergies and development of the foundations of health, research and welfare” This meeting aims to show and value the important work that health, scientific research and social welfare foundations play in our country […]
IDIVAL's Clinical and Molecular Microbiology group has participated in a study about the evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone. Pseudomonas aeruginosa chronic respiratory infection (CRI) is the main driver of morbidity and mortality in patients suffering from cystic fibrosis (CF). The CF respiratory tract is a dynamic, heterogeneous, […]
The first genome-wide association study (GWAS) in IgA vasculitis worldwide has been conducted by the research group of IDIVAL “Genetic epidemiology and atherosclerosis in systemic inflammatory diseases”, led by Dr. Miguel Ángel González-Gay, in collaboration with other Hospitals and national and international Institutes. Immunoglobulin-A (IgA) vasculitis, also known as Henoch-Schöenlein purpura (HSP), is the most […]
